leukemia
137 projects
HEIndividual fellowship2026–2029Germany
MPN2AML · Identification of novel genetic regulators governing leukaemic transformation from myeloid proliferative neoplasms
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
NeutroMPN · Role of CD24 and CD24hi Neutrophils in key co-morbidities associated with the MyeloProliferative Neoplasms
2 partners · 2 countries
HEIndividual fellowship2026–2028Belgium
RasWayToALL · Role of RAS mutant subclones in the development of High Hyperdiploid B-ALL
HEDoctoral network2025–2029Spain
ACHILLES · Advancing in the CHallenge of Improving Lymphoma and LEukemia Survival
33 partners · 12 countries
HEIndividual fellowship2025–2027Spain
RETRO · Relapse in T-ALL: Resistant Clones and Therapeutical Options
2 partners
HEIndividual fellowship2025–2027Netherlands
MarrowMimi · A bone marrow mimicry bioreactor for cost effective production of hematopoietic stem cells
HEIndividual fellowship2025–2026Netherlands
SMART-AML · Shaping Marrow Adiposity to Redefine Treatment in Acute Myeloid Leukemia
HEDoctoral network2024–2028Netherlands
MIRACLE · Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
22 partners · 8 countries
HEIndividual fellowship2024–2027Netherlands
BEAT B-cell Lymphoma · Biomarkers of Effective CART19 Assessed in the Tissue Microenvironment
2 partners · 2 countries
HEIndividual fellowship2024–2026Belgium
PyroVector · Selective induction of PYROptosis in acute myeloid leukemia cells with VECTORized DPP9 inhibitors
HECOFUND2024–2029Spain
CarrerasPathfinders · Enabling the next generation in search of blood cancer cures
47 partners · 18 countries
HEIndividual fellowship2024–2026Spain
ChroMet · Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.
HEIndividual fellowship2023–2025Israel
PRELEUKMEC · Deciphering the intrinsic and extrinsic mechanisms shaping aging and leukemic evolution of hematopoietic stem cells at the single cell level
HEIndividual fellowship2023–2025Belgium
DPP9-TACDrug · DPP9 degradation-induced pyroptosis for treatment of acute myeloid leukemia
HEIndividual fellowship2023–2025Germany
MRDAML · Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myeloid leukemia
HEIndividual fellowship2023–2024Spain
StemLinc · Identification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia.
HEIndividual fellowship2023–2026Spain
ALERT · Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia
2 partners
HEIndividual fellowship2022–2024Austria
B-ALLeles · High resolution dissection of non-coding determinants of disease
2 partners
HEIndividual fellowship2022–2024Germany
SESAHME · Spatially rEsolved Single-cell Approaches in Haematologic MalignanciEs
HEIndividual fellowship2022–2024Germany
engineereD to Clear · Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia
H2020Individual fellowship2022–2024Germany
DIEAML · Deciphering immune evasion of Acute Myeloid Leukemia
H2020Individual fellowship2022–2024Italy
BCRES-CLL · B cell receptor engagement and signalling in chronic lymphocytic leukemia: identify the structural and functional requirements for disease development and progression.
H2020Individual fellowship2022–2024Austria
AML-SynergyX · Systematic identification of genetic modifiers in the response to targeted therapies in acute myeloid leukemia.
H2020Individual fellowship2022–2024Norway